World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
67
Citations
14578
World Ranking
2290
National Ranking
940

Medicine

D-Index
74
Citations
17612
World Ranking
19472
National Ranking
9691

Eric L. Nuermberger publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Eric L. Nuermberger sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 207 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Eric L. Nuermberger D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Eric L. Nuermberger sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 67 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Eric L. Nuermberger is affiliated with Johns Hopkins University in the United States. Their research focuses primarily on Medicine, with notable contributions in Biochemistry, Genetics and Molecular Biology. Within these broad fields, their work has significant emphasis on Infectious Diseases, Epidemiology, Molecular Biology, Surgery, and Molecular Medicine.

The main topics of Eric L. Nuermberger's work include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Cancer therapeutics and mechanisms, Pneumocystis jirovecii pneumonia detection and treatment, Antibiotic Resistance in Bacteria, Infectious Diseases and Tuberculosis, and Antibiotics Pharmacokinetics and Efficacy.

They have published extensively in a range of scientific journals. The most frequent publication venues are:

  • Antimicrobial Agents and Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Nature Communications
  • ACS Infectious Diseases

Eric L. Nuermberger has collaborated with several co-authors, notable among them are:

  • Paul J. Converse
  • Rokeya Tasneen
  • Nader Fotouhi
  • Si-Yang Li
  • Deepak V. Almeida

Recent publications by Eric L. Nuermberger include:

  • Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis, 2020, Antimicrobial Agents and Chemotherapy
  • Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering, 2020, PLoS Pathogens
  • Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing, 2021, mBio
  • Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial, 2023, The Lancet Respiratory Medicine
  • Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis, 2021, Antimicrobial Agents and Chemotherapy

Best Publications

  • Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.

    Nicola Zetola;John S Francis;Eric L Nuermberger;William R Bishai

  • Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes

    John S. Francis;Meg C. Doherty;Uri Lopatin;Cecilia P. Johnston

  • The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley

  • Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

    Eric L. Nuermberger;Tetsuyuki Yoshimatsu;Sandeep Tyagi;Richard J. O'Brien

  • Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

    Susan E. Dorman;John L. Johnson;Stefan Goldberg;Grace Muzanye

  • Targeting DnaN for tuberculosis therapy using novel griselimycins

    Angela Kling;Peer Lukat;Deepak V. Almeida;Armin Bauer

  • Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice

    Petros C. Karakousis;Tetsuyuki Yoshimatsu;Gyanu Lamichhane;Samuel C. Woolwine

  • Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions

    Jamie Harper;Ciaran Skerry;Stephanie L. Davis;Rokeya Tasneen

  • Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis

    Sandeep Tyagi;E. Nuermberger;T. Yoshimatsu;K. Williams

  • Promising Clinical Efficacy of Streptomycin-Rifampin Combination for Treatment of Buruli Ulcer (Mycobacterium ulcerans Disease)

    Annick Chauty;Marie Françoise Ardant;Ambroise Adeye;Hélène Euverte

  • Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis

    Eric L. Nuermberger;Tetsuyuki Yoshimatsu;Sandeep Tyagi;Kathy Williams

  • Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis

    Scott G. Franzblau;Mary Ann DeGroote;Sang Hyun Cho;Koen Andries

  • Daily Dosing of Rifapentine Cures Tuberculosis in Three Months or Less in the Murine Model

    Ian M Rosenthal;Ming Zhang;Kathy N Williams;Charles A Peloquin

  • Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model

    K. N. Williams;C. K. Stover;T. Zhu;R. Tasneen

  • Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

    Eric Nuermberger;Sandeep Tyagi;Rokeya Tasneen;Kathy N. Williams

  • Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis

    Rokeya Tasneen;Si Yang Li;Charles A. Peloquin;Dinesh Taylor

  • Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

    Deepak Almeida;Thomas Ioerger;Sandeep Tyagi;Si Yang Li

  • Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.

    Scott M. Irwin;Emily Driver;Edward Lyon;Christopher Schrupp

  • Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis

    Kathy Williams;Austin Minkowski;Opokua Amoabeng;Charles A. Peloquin

  • Role of the dosR-dosS Two-Component Regulatory System in Mycobacterium tuberculosis Virulence in Three Animal Models†

    Paul J. Converse;Petros C. Karakousis;Lee G. Klinkenberg;Anup K. Kesavan

Frequent Co-Authors

Jacques H. Grosset
Jacques H. Grosset Johns Hopkins University School of Medicine
William R. Bishai
William R. Bishai Johns Hopkins University
Petros C. Karakousis
Petros C. Karakousis Johns Hopkins University
Tawanda Gumbo
Tawanda Gumbo Baylor University Medical Center
Richard E. Chaisson
Richard E. Chaisson Johns Hopkins University
Véronique Dartois
Véronique Dartois Rutgers, The State University of New Jersey
James C. Sacchettini
James C. Sacchettini Texas A&M University
Soumya Swaminathan
Soumya Swaminathan M S Swaminathan Research Foundation
Thomas R. Ioerger
Thomas R. Ioerger Texas A&M University
Barry N. Kreiswirth
Barry N. Kreiswirth Center for Discovery and Innovation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary careers, especially in healthcare and information management. For those interested in the administrative and coding side of healthcare, pursuing a certified professional coder (cpc) credential can be a rewarding path. This certification ensures expertise in medical coding, a vital aspect of healthcare documentation.

Another promising role is that of a health information manager. Entry-level opportunities often require strong knowledge of healthcare data systems and compliance. Understanding the health information management salary entry-level can help prospective students evaluate their career potential early on.

To prepare for these paths, consider accredited programs such as those listed under online health information management degree programs cahiim accredited. These programs ensure quality education that meets industry standards for health information professionals.

For individuals looking to start quickly, an accelerated medical billing and coding certificate online offers a streamlined pathway into the field. These certificates provide essential skills and credentials in less time, making them ideal for those eager to enter the workforce.

Best Scientists Citing Eric L. Nuermberger

Trending Scientists

Recently Published Articles